Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis

Author: Wu Kai-Da   Zhou Li   Burtrum Douglas   Ludwig Dale   Moore Malcolm  

Publisher: Springer Publishing Company

ISSN: 0340-7004

Source: Cancer Immunology, Immunotherapy, Vol.56, Iss.3, 2007-03, pp. : 343-357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content